The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
Open accessAbstract
Spatial and temporal dissection of the genomic changes occurring during the evolution of human non–small cell lung cancer (NSCLC) may help elucidate the basis for its dismal prognosis. We sequenced 25 spatially distinct regions from seven operable NSCLCs and found evidence of branched evolution, with driver mutations arising before and after subclonal diversification. There was pronounced intratumor heterogeneity in copy number alterations, translocations, and mutations associated with APOBEC cytidine deaminase activity. Despite maintained carcinogen exposure, tumors from smokers showed a relative decrease in smoking-related mutations over time, accompanied by an increase in APOBEC-associated mutations. In tumors from former smokers, genome-doubling occurred within a smoking-signature context before subclonal diversification, which suggested that a long period of tumor latency had preceded clinical detection. The regionally separated driver mutations, coupled with the relentless and heterogeneous nature of the genome instability processes, are likely to confound treatment success in NSCLC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While the full extent to which mutational processes account for unique combinations of somatic genomic alterations in NSCLC is currently unknown, there is evidence that APOBEC-mediated mutagenesis fuels sub-clonal diversification and branched evolution78, 79.”
From Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy (2019) · cites this paper as [79]
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Estimating the Dimension of a Model
Schwarz, G. (1978) · The Annals of Statistics · doi:10.1214/aos/1176344136 · Cited by 47,033
Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M., & Kumar, S. (2011) · Molecular Biology and Evolution · doi:10.1093/molbev/msr121 · Cited by 40,166
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,724
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Circos: An information aesthetic for comparative genomicsPreprint
Krzywinski, M. I., Schein, J. E., Birol, İ., Connors, J. M., Gascoyne, R. D., Horsman, D. E., Jones, S. J. M., & Marra, M. A. (2009) · Genome Research · doi:10.1101/gr.092759.109 · Cited by 11,073
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Self-citation<tt>BLAT</tt> —The <tt>BLAST</tt> -Like Alignment Tool
Kent, W. J. (2002) · Genome Research · doi:10.1101/gr.229202 · Cited by 8,480
Flagged first, then by citations
Research works printed but not linked: 1
- Soria J. C., Cruz C., Bahleda R., Delord J. P., Horn L., Herbst R. S., Spigel D., Mokatrin A., Fine G., Gettinger S., Clinical activity, safety and biomarkers of PD-L1 blockade in non-small cell lung cancer (NSCLC). Eur. J. Cancer 49 (suppl. 2), 3408 (2013).
Cited by
Sorted by citations
Items 501–600 of 1,000
Liu, M., Chen, J., Wang, X., Wang, C., Zhang, X., Xie, Y., Zuo, Z., Ren, J. M., & Zhao, Q. (2021) · GigaScience · doi:10.1093/gigascience/giab036 · Cited by 26
The potential diagnostic power of circulating tumor cell analysis for non-small-cell lung cancer
Ross, K., Pailler, E., Faugeroux, V., Taylor, M., Oulhen, M., Auger, N., Planchard, D., Soria, J., Lindsay, C. R., Besse, B., et al. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1111139 · Cited by 31
Implications of Tumor Clonal Heterogeneity in the Era of Next-Generation Sequencing
Jacoby, M. A., Duncavage, E. J., & Walter, M. J. (2015) · Trends in cancer · doi:10.1016/j.trecan.2015.10.006 · Cited by 29
Osimertinib for EGFR T790M mutation-positive non-small cell lung cancer
Soejima, K., Yasuda, H., & Hirano, T. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1265446 · Cited by 31
Suda, K., Kim, J., Murakami, I., Rozeboom, L. M., Shimoji, M., Shimizu, S., Rivard, C. J., Mitsudomi, T., Tan, A. C., & Hirsch, F. R. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.05.039 · Cited by 30
Shao, Y., Wang, Y., Yu, H., Zhang, Y., Xiang, F., Yang, Y. J., Yang, Y. S., Li, L., Dong, S., Yang, D., et al. (2018) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2018.10.266 · Cited by 28
Legras, A., Roussel, H., Mangiameli, G., Arame, A., Grand, B., Pricopi, C., Badia, A., Gibault, L., Badoual, C., Fabre, E., et al. (2017) · Pathology & Oncology Research · doi:10.1007/s12253-017-0352-x · Cited by 27
Deng, Q., Xie, B., Wu, L., Ji, X., Li, C., Li, F., Fang, Q., Bao, Y., Li, J., Jin, S., et al. (2018) · Heliyon · doi:10.1016/j.heliyon.2018.e01031 · Cited by 27
Detecting truly clonal alterations from multi-region profiling of tumours
Werner, B., Traulsen, A., Sottoriva, A., & Dingli, D. (2017) · Scientific Reports · doi:10.1038/srep44991 · Cited by 28
Yuan, Y., Huang, Q., Gu, C., & Chen, H. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.12.58 · Cited by 27
Pei, G., Li, M., Min, X., Liu, Q., Li, D., Yang, Y., Wang, S., Wang, X., Wang, H., Cheng, H., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.653988 · Cited by 27
Passive Smoking–Induced Mutagenesis as a Promoter of Lung Carcinogenesis
Mochizuki, A., Shiraishi, K., Honda, T., Higashiyama, R. I., Sunami, K., Matsuda, M., Shimada, Y., Miyazaki, Y., Yoshida, Y., WATANABE, S.-I. I., et al. (2024) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2024.02.006 · Cited by 27
Kachuri, L., Latifovic, L., Liu, G., & Hung, R. J. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0200 · Cited by 27
Constraints in cancer evolution
Venkatesan, S., Birkbak, N. J., & Swanton, C. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160229 · Cited by 28
Self-citationA Review of Recent Advances in Translational Bioinformatics: Bridges from Biology to Medicine
Vamathevan, J. J., & Birney, E. (2017) · Yearbook of Medical Informatics · doi:10.15265/iy-2017-017 · Cited by 27
Wangsa, D., Braun, R., Schiefer, M., Gertz, E. M., Bronder, D., Quintanilla, I., Padilla‐Nash, H. M., Torres, I. M., Hunn, C., Warner, L., et al. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy068 · Cited by 28
Perturbation-Driven Entropy as a Source of Cancer Cell Heterogeneity
Nijman, S. M. B. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.02.016 · Cited by 27
Noorani, I., de la Rosa, J., Choi, Y., Strong, A. J., Ponstingl, H., Vijayabaskar, M., Lee, J.-S., Lee, E., Richard-londt, A., Friedrich, M. J., et al. (2020) · Genome Biology · doi:10.1186/s13059-020-02092-2 · Cited by 26
Clonal evolution and hierarchy in myeloid malignancies
Takahashi, K., & Tanaka, T. N. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.05.004 · Cited by 28
Pan, Y., Luan, X., Zeng, F., Wang, X., Qin, S., Lu, Q., He, G., Gao, Y., Sun, X., Han, X., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.09.016 · Cited by 27
Feasibility of Cell-Free Circulating Tumor DNA Testing for Lung Cancer
Santarpía, M., Karachaliou, N., González‐Cao, M., Altavilla, G., Giovannetti, E., & Rosell, R. (2016) · Biomarkers in Medicine · doi:10.2217/bmm.16.6 · Cited by 26
EGFR T790M mutation testing within the osimertinib AURA Phase I study
Dearden, S. P., Brown, H. J., Jenkins, S. C., Thress, K. S., Cantarini, M., Cole, R. T., Ranson, M., & Janne, P. A. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.04.011 · Cited by 26
Targeted Therapy for Non-Small Cell Lung Cancer
Noor, Z. S., Cummings, A. L., Johnson, M. M., Spiegel, M. L., & Goldman, J. W. (2020) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1700994 · Cited by 27
Periyasamy, M., Singh, A. K., Gemma, C., Farzan, R. A., Allsopp, R. C., Shaw, J., Charmsaz, S., Young, L. S., Cunnea, P., Coombes, R. C., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01583-7 · Cited by 26
Beyond Sequencing: Prioritizing and Delivering Neoantigens for Cancer Vaccines
Roesler, A. S., & Anderson, K. S. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1884-4_35 · Cited by 26
Molecular pathology of non‐small cell carcinoma
Yatabe, Y. (2023) · Histopathology · doi:10.1111/his.15080 · Cited by 30
Lee, J., Li, B., Cui, Y., Sun, X., Wu, J., Zhu, H., Yu, J., Gensheimer, M. F., Loo, B. W., Diehn, M., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.01.006 · Cited by 26
Ji, T., Zhang, L., Deng, M., Huang, S., Wang, Y., Pham, T. T., Smith, A. A., Sridhar, V., Cabernard, C., Wang, J., et al. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.040147 · Cited by 25
Tuo, Z., Zhang, Y., Li, D., Wang, Y., Wu, R., Wang, J., Yu, Q., Ye, L., Shao, F., Wusiman, D., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107302 · Cited by 28
The Evolutionary Forest of Pancreatic Cancer
Mullen, K. M., Hong, J., Attiyeh, M. A., Hayashi, A., Sakamoto, H., Kohutek, Z. A., McIntyre, C. A., Zhang, H., Makohon-Moore, A. P., Zucker, A., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-1541 · Cited by 26
BARD1 serum autoantibodies for the detection of lung cancer
Pilyugin, M., Descloux, P., André, P., László, V., Döme, B., Hegedűs, B., Sardy, S., Janes, S. M., Bianco, A., Laurent, G. J., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182356 · Cited by 25
Self-citationRadiogenomics in Interventional Oncology
Moussa, A. M., & Ziv, E. (2021) · Current Oncology Reports · doi:10.1007/s11912-020-00994-9 · Cited by 26
Impact of crowding on the diversity of expanding populations
Schreck, C. F., Fusco, D., Karita, Y., Martis, S., Kayser, J., Duvernoy, M.-C., & Hallatschek, O. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2208361120 · Cited by 25
The role of ctDNA detection and the potential of the liquid biopsy for breast cancer monitoring
Openshaw, M. R., Page, K., Fernández-García, D., Guttery, D. S., & Shaw, J. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2016.1184974 · Cited by 27
Minimum Latency & Types or Categories of Cancer
Howard, J. (2014) · Cited by 25
Davidson, M. A., & Shanks, E. (2017) · The FEBS Journal · doi:10.1111/febs.14061 · Cited by 23
Understanding Intratumor Heterogeneity and Evolution in NSCLC and Potential New Therapeutic Approach
Goto, T., Hirotsu, Y., Amemiya, K., Mochizuki, H., & Omata, M. (2018) · Cancers · doi:10.3390/cancers10070212 · Cited by 25
Clinical implications of molecular subtyping in bladder cancer
Satyal, U., Sikder, R. K., McConkey, D. J., Plimack, E. R., & Abbosh, P. H. (2019) · Current Opinion in Urology · doi:10.1097/mou.0000000000000641 · Cited by 25
Multiple Molecular Targets Associated with Genomic Instability in Lung Cancer
Soca‐Chafre, G., Montiel‐Dávalos, A., Rosa-Velázquez, I. A. D. L., Caro-Sánchez, C. H. S., Peña‐Nieves, A., & Arrieta, O. G. (2019) · International Journal of Genomics · doi:10.1155/2019/9584504 · Cited by 24
Molecular Characterisation of Canine Osteosarcoma in High Risk Breeds
Simpson, S., Dunning, M., de Brot, S., Alibhai, A. A., Bailey, C., Woodcock, C. L., Mestas, M., Akhtar, S., Jeyapalan, J. N., Lothion‐Roy, J. H., et al. (2020) · Cancers · doi:10.3390/cancers12092405 · Cited by 26
Cancer stem cells modulate patterns and processes of evolution in cancers
Laplane, L. (2018) · Biology & Philosophy · doi:10.1007/s10539-018-9629-z · Cited by 26
APOBEC Mutagenesis in Cancer Development and Susceptibility
Dananberg, A., Striepen, J., Rozowsky, J. S., & Petljak, M. (2024) · Cancers · doi:10.3390/cancers16020374 · Cited by 28
Modeling lung adenocarcinoma metastases using patient-derived organoids
Liu, Y., Lankadasari, M. B., Rosiene, J. A., Johnson, K. E., Zhou, J., Bapat, S., Chow-Tsang, L.-F., Tian, H., Mastrogiacomo, B., He, D., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101777 · Cited by 25
Self-citationWeeden, C. E., Holik, A. Z., Young, R. J., Ma, S. B., Garnier, J.-M., Fox, S. B., Antippa, P. N., Irving, L. B., Steinfort, D., Wright, G. M., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0174 · Cited by 24
Krause, A., Roma, L., Lorber, T., Habicht, J. M., Lardinois, D., Filippo, M. R. D., Prince, S. S., Piscuoglio, S., Ng, C. K. Y., & Bubendorf, L. (2020) · Lung Cancer · doi:10.1016/j.lungcan.2020.10.013 · Cited by 24
Mas-Ponte, D., McCullough, M., & Supek, F. (2022) · Clinical Science · doi:10.1042/cs20210682 · Cited by 24
Adler, N., Bahcheli, A. T., Cheng, K., Al‐Zahrani, K. N., Slobodyanyuk, M., Pellegrina, D. V. D. S., Schramek, D., & Reimand, J. (2023) · Science Advances · doi:10.1126/sciadv.adh3083 · Cited by 30
Determining the origin of synchronous multifocal bladder cancer by exome sequencing
Acar, Ö., Özkurt, E., Demir, G., Saraç, H., Alkan, C., Esen, T., Somel, M., & Lack, N. A. (2015) · BMC Cancer · doi:10.1186/s12885-015-1859-8 · Cited by 24
Kjällquist, U., Erlandsson, R., Tobin, N., Alkodsi, A., Ullah, I., Stålhammar, G., Karlsson, E., Hatschek, T., Hartman, J., Linnarsson, S., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4021-6 · Cited by 22
Ren, Y., Huang, S., Dai, C., Xie, D., Zheng, L., Xie, H., Zheng, H., She, Y., Zhou, F., Wang, Y., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00288 · Cited by 25
Moghaddam, S. J., Savai, R., Salehi‐Rad, R., Sengupta, S., Kammer, M. N., Massion, P. P., Beane, J., Ostrin, E. J., Priolo, C., Tennis, M. A., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202406-1168st · Cited by 26
Detection and Characterization of Circulating Tumour Cells in Multiple Myeloma
Zhang, L., Beasley, S., Prigozhina, N. L., Higgins, R., Ikeda, S., Lee, F. Y., Marrinucci, D. C., & Jia, S. (2016) · Journal of Circulating Biomarkers · doi:10.5772/64124 · Cited by 23
Govindan, R. (2014) · Science · doi:10.1126/science.1259926 · Cited by 23
Thorat, M. A., Levey, P. M., Jones, J. L., Pinder, S. E., Bundred, N. J., Fentiman, I. S., & Cuzick, J. M. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4635 · Cited by 23
Markou, A. N., Londra, D., Stergiopoulou, D., Vamvakaris, I. N., Potaris, Κ., Pateras, I. S., Kotsakis, A. P., Georgoulias, V., & Lianidou, E. S. (2023) · Cancers · doi:10.3390/cancers15061877 · Cited by 22
Chang, J. C., & Rekhtman, N. (2024) · Modern Pathology · doi:10.1016/j.modpat.2024.100453 · Cited by 26
NSAID use and somatic exomic mutations in Barrett’s esophagus
Galipeau, P. C., Oman, K. M., Paulson, T. G., Sanchez, C. A., Zhang, Q., Marty, J. A., Delrow, J. J., Kuhner, M. K., Vaughan, T. L., Reid, B. J., et al. (2018) · Genome Medicine · doi:10.1186/s13073-018-0520-y · Cited by 20
El‐Deiry, W. S., Taylor, B. S., & Neal, J. W. (2017) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_175524 · Cited by 28
The Value of Patient and Public Involvement in Trial Design and Development
Gasson, S., Bliss, J. M., Jamal‐Hanjani, M., Krebs, M., Swanton, C., & Wilcox, M. (2015) · Clinical Oncology · doi:10.1016/j.clon.2015.06.020 · Cited by 23
Self-citationEngineering Multidimensional Evolutionary Forces to Combat Cancer
McCoach, C. E., & Bivona, T. G. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1196 · Cited by 23
Jiang, X., Xiao, G., & Li, Q. (2022) · Statistics in Medicine · doi:10.1002/sim.9530 · Cited by 22
Multilayer spectrum of intratumoral heterogeneity in basal bladder cancer
Sirab, N., Drubay, D., Maillé, P., Popova, T. G., Duong-Ngo, C., Gentien, D., Moktefi, A., Soyeux, P., Pelletier, R., Réyès, C., et al. (2021) · The Journal of Pathology · doi:10.1002/path.5813 · Cited by 22
Age at diagnosis, obesity, smoking, and molecular subtypes in muscle-invasive bladder cancer
Sun, X., Hoadley, K. A., Kim, W. Y., Furberg, H. F., Olshan, A. F., & Troester, M. A. (2017) · Cancer Causes & Control · doi:10.1007/s10552-017-0885-z · Cited by 22
Bak, S. H., Park, H., Lee, H. Y., Kim, Y.-W., Kim, H., Jung, S., Kim, H. S., Kim, J., & Park, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-21706-1 · Cited by 23
Cho, S., Chae, J., Na, D., Kang, W., Lee, A., Min, S., Kang, J., Choi, B., Lee, J. L., Sung, C. O., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3460 · Cited by 22
Self-citationGenomic landscape of allelic imbalance in premalignant atypical adenomatous hyperplasias of the lung
Sivakumar, S., Lucas, F. A. S., Jakubek, Y. A., McDowell, T. L., Lang, W., Kallsen, N. A., Peyton, S., Davies, G. E., Fukuoka, J., Yatabe, Y., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.020 · Cited by 21
Intratumoural heterogeneity and clone evolution of oral squamous cell carcinoma
Wang, L., Wang, X., Jia, Y., Guo, F., Zheng-jun, S., & Shao, Z. (2021) · Molecular Carcinogenesis · doi:10.1002/mc.23341 · Cited by 22
van den Bosch, T., Derks, S., & Miedema, D. M. (2022) · Cancers · doi:10.3390/cancers14204986 · Cited by 21
Butt, Y., Sakhtemani, R., Mohamad-Ramshan, R., Lawrence, M. S., & Bhagwat, A. S. (2024) · Nature Communications · doi:10.1038/s41467-024-46231-w · Cited by 21
Um, S., Joung, J., Lee, H. J., Kim, H., Kim, K.-T., Park, J., Hayes, D. N., & Park, W. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0873 · Cited by 21
Biospecimen Complexity—the Next Challenge for Cancer Research Biobanks?
Watson, P. H. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1406 · Cited by 21
Gao, J., Choudhry, H., & Cao, W. (2018) · Cancer Science · doi:10.1111/cas.13658 · Cited by 22
Kobayashi, K., & Tan, A. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044126 · Cited by 22
Polyploidy in Cancer: Causal Mechanisms, Cancer-Specific Consequences, and Emerging Treatments
Conway, P. J., Dao, J., Kovalskyy, D., Mahadevan, D., & Dray, E. V. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0578 · Cited by 22
Accounting for Errors in Data Improves Divergence Time Estimates in Single-cell Cancer Evolution
Chen, K., Moravec, J. C., Gavryushkin, A., Welch, D., & Drummond, A. J. (2022) · Molecular Biology and Evolution · doi:10.1093/molbev/msac143 · Cited by 20
Tabata, M., Sato, Y., Kogure, Y., McClure, M. B., Oshikawa-Kumade, Y., Saito, Y., Shingaki, S., Ito, Y., Yuasa, M., Koya, J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112736 · Cited by 19
Engineering Heterogeneous Tumor Models for Biomedical Applications
Wu, Z., Huang, D., Wang, J., Zhao, Y., Sun, W., & Shen, X. (2023) · Advanced Science · doi:10.1002/advs.202304160 · Cited by 19
In vivo DNA replication dynamics unveil aging-dependent replication stress
Rossetti, G. G., Dommann, N., Karamichali, A., Dionellis, V. S., Aldave, A. A., Yarahmadov, T., Rodríguez-Carballo, E., Keogh, A., Candinas, D., Stroka, D., et al. (2024) · Cell · doi:10.1016/j.cell.2024.08.034 · Cited by 22
Visualization of tumor heterogeneity by in situ padlock probe technology in colorectal cancer
Heliebi, A. E., Kashofer, K., Fuchs, J., Jahn, S. W., Viertler, C., Matak, A., Sedlmayr, P., & Höefler, G. (2017) · Histochemistry and Cell Biology · doi:10.1007/s00418-017-1557-5 · Cited by 20
Cancer as an ecomolecular disease and a neoplastic consortium
y Cajal, S. R., Capdevila, C., Hernández‐Losa, J., Mattos‐Arruda, L. D., Ghosh, A., Lorent, J., Larsson, O. S., Aasen, T., Postovit, L.-M. M., & Topisirović, I. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.09.004 · Cited by 20
Immuno-oncology from the perspective of somatic evolution
González, S., Volkova, N. V., Beer, P. A., & Gerstung, M. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.12.001 · Cited by 20
Human papillomavirus and oropharyngeal cancer
Villa, A., & Hanna, G. J. (2018) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2018.06.005 · Cited by 21
Yuan, W., Liu, Z., Wang, Y., Liu, M., Pan, Y., Lei, W., Yang, H., Xu, R., Zhang, L., Cai, H., et al. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz162 · Cited by 20
Schuurbiers, M. M. F., Huang, Z., Saelee, S. L., Javey, M., de Visser, L., van den Broek, D. A., van den Heuvel, M. M., Lovejoy, A. F., Monkhorst, K., & Klass, D. M. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004064 · Cited by 20
Zhang, X., Nguyen, K. D. P., Rudnick, P. A., Roper, N., Kawaler, E. A., Maity, T. K., Awasthi, S., Gao, S., Biswas, R., Venugopalan, A. K., et al. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.001266 · Cited by 20
Clonality analysis of pulmonary tumors by genome-wide copy number profiling
Vincenten, J. P. L., Essen, H. F. H. V., Lissenberg-Witte, B. I., Bulkmans, N. W. J., Krijgsman, O., Sie, D., Eijk, P. P., Smit, E. F., Ylstra, B., & Thunnissen, E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223827 · Cited by 21
Beck, A. H. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001794 · Cited by 20
Xiao, Y., Jin, W., Qian, K., Ju, L., Wang, G., Jiang, W., Cao, R., Ju, L., Zhao, Y., Zheng, H., et al. (2024) · Advanced Science · doi:10.1002/advs.202308438 · Cited by 24
Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma
Ramirez, C. A., Becker‐Hapak, M., Singhal, K., Russler‐Germain, D. A., Frenkel, F. E., Barnell, E. K., McClain, E. D., Desai, S., Schappe, T., Onyeador, O. C., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2022007792 · Cited by 20
Genetic Clonality as the Hallmark Driving Evolution of Non-Small Cell Lung Cancer
Nicoś, M., & Krawczyk, P. A. (2022) · Cancers · doi:10.3390/cancers14071813 · Cited by 21
Williams, S. C. P. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500963112 · Cited by 19
Lee, J., Cui, Y., Sun, X., Li, B., Wu, J., Li, D., Gensheimer, M. F., Loo, B. W., Diehn, M., & Li, R. (2017) · European Radiology · doi:10.1007/s00330-017-4996-4 · Cited by 19
Li, X., & Thirumalai, D. (2019) · Journal of The Royal Society Interface · doi:10.1098/rsif.2018.0820 · Cited by 18
Liu, H., Zhao, H., & Li, W. (2019) · Technology in Cancer Research & Treatment · doi:10.1177/1533033819827317 · Cited by 19
Untangling the evolutionary roots of lung cancer
Devarakonda, S. H. K., & Govindan, R. (2019) · Nature Communications · doi:10.1038/s41467-019-10879-6 · Cited by 18
Comprehensive study of neoadjuvant targeted therapy for resectable non-small cell lung cancer
Bao, Y., Gu, C., Xie, H., Zhao, S., Xie, D., Chen, C., Jiang, G., Dai, C., & Zhu, Y. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-1134 · Cited by 19
Fu, Y., Wang, A., Zhou, J., Feng, W., Shi, M., Xu, X., Zhao, H., Cai, L., Feng, J., Lv, X., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.621992 · Cited by 21
Schmidt, M., HACKETT, R. J., Baker, A., McDonald, S. A. C., Quante, M., & Graham, T. A. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00531-4 · Cited by 17
Mortusewicz, O., Haslam, J., Gad, H., & Helleday, T. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.04.015 · Cited by 20
Melocchi, V., Dama, E., Mazzarelli, F., Cuttano, R., Colangelo, T., Candia, L. D., Lugli, E., Veronesi, G., Pelosi, G., Ferretti, G. M., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01909-z · Cited by 18
Metadata
- Authors
- de Bruin, E. C., McGranahan, N., Mitter, R., Salm, M., Wedge, D. C., Yates, L., Jamal-Hanjani, M., Shafi, S., Murugaesu, N., Rowan, A. J., Grönroos, E., Muhammad, M. A., Horswell, S., Gerlinger, M., Varela, I., Jones, D., Marshall, J., Voet, T., Van Loo, P., Rassl, D. M., Rintoul, R. C., Janes, S. M., Lee, S.-M., Forster, M., Ahmad, T., Lawrence, D., Falzon, M., Capitanio, A., Harkins, T. T., Lee, C. C., Tom, W., Teefe, E., Chen, S.-C., Begum, S., Rabinowitz, A., Phillimore, B., Spencer-Dene, B., Stamp, G., Szallasi, Z., Matthews, N., Stewart, A., Campbell, P., & Swanton, C.
- Affiliations
- Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6BT, UK.
- Cancer Research UK (GB)
- Wellcome Sanger Institute (GB)
- University of Cambridge (GB)
- Cancer Research UK London Research Institute, London WC2A 3LY, UK.
- Universidad de Cantabria (ES)
- Wellcome Trust Sanger Institute, Hinxton, CB10 1SA, UK.
- Papworth Hospital NHS Foundation Trust (GB)
- University College London (GB)
- Thermo Fisher Scientific (United States) (US)
- Technical University of Denmark, 2800 Kongens Lyngby, Denmark.
- Corresponding author
- McGranahan, Nicholas
- Mitter, Richard
- Salm, Max
- Wedge, David C.
- Yates, Lucy
- Swanton, Charles
- ORCID
- McGranahan, Nicholas
- Mitter, Richard
- Salm, Max
- Wedge, David C.
- Yates, Lucy
- Murugaesu, Nirupa
- Rowan, Andrew J.
- Horswell, Stuart
- Gerlinger, Marco
- Varela, Ignacio
- Jones, David
- Voet, Thierry
- Rassl, Doris M.
- Rintoul, Robert C.
- Janes, Sam M.
- Lee, Siow-Ming
- Forster, Martin
- Lawrence, David
- Falzon, Mary
- Capitanio, Arrigo
- Harkins, Timothy T.
- Lee, Clarence C.
- Teefe, Enock
- Begum, Sharmin
- Rabinowitz, Adam
- Stamp, Gordon
- Matthews, Nik
- Campbell, Peter
- Swanton, Charles
- Venue
- Science
- Published
- 2014-10-10
- Volume
- 346
- Issue
- 6206
- Pages
- 251-256
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2108371618
- Cited by
- 1,117
- References
- 62
- Citations by year
- 2026: 38 · 2025: 43 · 2024: 59 · 2023: 82 · 2022: 82 · 2021: 86 · 2020: 99 · 2019: 113 · 2018: 111 · 2017: 145 · 2016: 131 · 2015: 119 · 2014: 9
- FWCI
- 43.17
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- UCrea (University of Cantabria) (acceptedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- Prostate Cancer Foundation
- Breast Cancer Research Foundation
- Wellcome Trust (091730, 105104, 088340)
- Cancer Research UK (259303, A11590, A4688, A17786, 17001, A19310, 17786, 18377)
- National Institute for Health and Care Research (CL-2011-18-001)
- Academy of Medical Sciences (AMS-SGCL7-Murugaesu)
- University College London
- European Commission (259303)
- Rosetrees Trust (M35-F1-CD1)
- Fonds Wetenschappelijk Onderzoek
- Ministerio de Economía y Competitividad
- Vlaamse regering
- National Institutes of Health
- Medical Research Council
- NIHR Cambridge Biomedical Research Centre
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- non-small cell lung cancer, tumor evolution, intratumoral heterogeneity, driver mutations, copy number alterations, chromosomal translocation, APOBEC mutational signature, genome doubling, tumor latency, carcinogen exposure, genomic instability
- MeSH terms
- APOBEC-1 Deaminase, Carcinogens, Carcinoma, Non-Small-Cell Lung, Cytidine Deaminase, Humans, Lung Neoplasms, Mutation, Neoplasm Recurrence, Local, Prognosis, Smoking, Translocation, Genetic, Tumor Cells, Cultured, Gene Dosage, Genetic Heterogeneity, Evolution, Molecular, Genomic Instability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
